Foreign investment continues to increase.Statement of work: Personal opinion, for reference only.
Thanks to the huge favorable blessing, today's market is once again anticlimactic, which once again disappoints retail investors. It is not surprising to say that the accident is not once or twice. But objectively speaking, this positive is indeed a real positive, and it is a medium-and long-term positive. I think we still have to treat it rationally, and institutions need to understand and reflect well. Is it necessary to go its own way? Today's trend can be said to be very ugly, so will the market have a big repair tomorrow? Let's analyze it in detail below.Listed companies can achieve extensive growth through mergers and acquisitions, and mergers and acquisitions have a positive effect on the overall share price of A-share listed companies as bidders. With the continuous increase of China's M&A support policies since 2024, the A-share market is expected to usher in a big era of M&A. The last merger and reorganization was so hot in 2014. Is this also a sign that the market will go bullish in the future?The General Office of the Shanghai Municipal People's Government issued the Action Plan for Shanghai to Support the Merger and Reorganization of Listed Companies (2025-2027). Among them, it is proposed to strive to land a number of representative M&A cases in key industries by 2027, and cultivate about 10 internationally competitive listed companies in key industries such as integrated circuits, biomedicine and new materials, forming a scale of M&A transactions of 300 billion yuan and activating total assets of over 2 trillion yuan.
The General Office of the Shanghai Municipal People's Government issued the Action Plan for Shanghai to Support the Merger and Reorganization of Listed Companies (2025-2027). Among them, it is proposed to strive to land a number of representative M&A cases in key industries by 2027, and cultivate about 10 internationally competitive listed companies in key industries such as integrated circuits, biomedicine and new materials, forming a scale of M&A transactions of 300 billion yuan and activating total assets of over 2 trillion yuan.Statement of work: Personal opinion, for reference only.Statement of work: Personal opinion, for reference only.
Strategy guide 12-13
Strategy guide 12-13
Strategy guide
12-13
Strategy guide 12-13